The persistent presence of APA, such as ACL, LAC, or anti-β2GPI, may lead to the development of antiphospholipid syndrome (APS), which may occur alone (primary APS) or in the presence of an autoimmune disease (secondary APS). This evidence concerns the gene ACLY and autoimmune polyendocrinopathy.